Small Molecules

08 May 2007 SRI International Reacquires Rights to Tirapazamine, a Phase III Cancer Drug
08 May 2007 Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results For AT-1001 For The Treatment Of Celiac Disease
08 May 2007 Genaera Corporation Initiates Human Study Of Obesity Compound Trodusquemine
08 May 2007 Bema(TM) Fentanyl Demonstrates Substantial Transmucosal Delivery In Absolute Bioavailability Study
08 May 2007 CollaGenex Pharmaceuticals Discontinues 40 mg Cohort of Phase II Dose-Finding Study of Incyclinide for the Treatment of Acne
08 May 2007 Gemin X Initiates a Phase 1 Trial with GMX1777 in Solid Tumors and Lymphomas
07 May 2007 Protelos(R): First Osteoporosis Treatment to Show Long-Term, Sustained Efficacy and Quality of Life Improvement
05 May 2007 Marinus Pharmaceuticals Initiates Phase IIb Study of Ganaxolone for Adult Partial Seizures
05 May 2007 PTC Therapeutics Announces Additional Positive Interim Phase 2 Results of PTC124 in Duchenne Muscular Dystrophy
05 May 2007 ISTA Provides Regulatory Update on T-Pred NDA Filing
05 May 2007 KAI Pharmaceuticals Initiates Phase 1 Trial of KAI-1455 for Ischemic Injury
05 May 2007 PTC Therapeutics Announces Additional Positive Interim Phase 2 Results of PTC124 in Duchenne Muscular Dystrophy
04 May 2007 Biovitrum Initiates Phase II Clinical Trial of Novel Pain Treatment
04 May 2007 Clinical Trial Results Suggest Long-Term Treatment Benefit of Tetrabenazine for Chorea Associated with Huntington's Disease
04 May 2007 Sequella Lead Drug SQ109 Completes Phase 1a Trial
04 May 2007 Array BioPharma Initiates Phase 1 Clinical Trial for Anticancer KSP Inhibitor ARRY-520
04 May 2007 ANX-201 Drug Combination Demonstrates Synergistic Activity Against Human and Bird Flu Viruses
04 May 2007 Incyte Reviews Progress in Multiple Drug Development Programs and Announces First Quarter 2007 Financial Results
04 May 2007 Data Suggest Cymbalta(R) Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
04 May 2007 Cipher Pharmaceuticals Receives Approvable Letter from FDA for CIP-TRAMADOL ER
04 May 2007 IntelGenx Technologies Corp. and Cary Pharmaceuticals Inc. Today Announced Positive Results From a First Pilot Pharmacokinetic (PK) Study On QuitPak (INT003/05)
04 May 2007 First patient enrolled in phase II study of BF-37 in atopic dermatitis
04 May 2007 Xanthus Presents Novel Approach for Autoimmune Disease Reversal with Symadex
04 May 2007 Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device Combination Product - ChronoDose
04 May 2007 Alpharma Presents Positive Pharmacokinetic Study Results of Its Investigational Abuse-Deterrent, Extended-Release Opioid

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up